Double Blinded Drug Discovery (DBD2): A New Protected Open Innovation Model
|
Wed30 May02:15pm(30 mins)
|
Where:
Lecture Hall
Speaker:
|
Discussion
The Lankenau Chemical Genomics Center (LCGC) is a totally new, automated molecular diversity depot (patents issued and pending) offering university networks access to diversity-clustered smart-snapshots (DCSS)™ from big Pharmas™ vast chemical collections, under a symbiotically transformative, public-private consortium for drug discovery research.Agenda
- Show Schedule
- Lectures by Time
- Lectures A to Z
- Lectures by Track
- Lectures by Speakers
- Lectures by Room
- Forums & Workshops
- Favourites
Hosted By
Select Biosciences Ltd.
Select Biosciences provides market reports, consultancy, training courses and conferences to the biomedical marketplace.
Select Biosciences Ltd.
Select Biosciences provides market reports, consultancy, training courses and conferences to the biomedical marketplace.